annual retained earnings:
$116.72B-$1.63B(-1.38%)Summary
- As of today (April 13, 2025), PFE annual retained earnings is $116.72 billion, with the most recent change of -$1.63 billion (-1.38%) on December 1, 2024.
- During the last 3 years, PFE annual retained earnings has risen by +$13.33 billion (+12.89%).
- PFE annual retained earnings is now -7.11% below its all-time high of $125.66 billion, reached on December 31, 2022.
Performance
PFE Retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly retained earnings:
$116.72B-$4.33B(-3.58%)Summary
- As of today (April 13, 2025), PFE quarterly retained earnings is $116.72 billion, with the most recent change of -$4.33 billion (-3.58%) on December 1, 2024.
- Over the past year, PFE quarterly retained earnings has stayed the same.
- PFE quarterly retained earnings is now -10.97% below its all-time high of $131.10 billion, reached on March 31, 2023.
Performance
PFE quarterly retained earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Retained earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PFE Retained earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | 0.0% |
| 3 y3 years | +12.9% | 0.0% |
| 5 y5 years | +19.5% | 0.0% |
PFE Retained earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -7.1% | +12.9% | -11.0% | +5.0% |
| 5 y | 5-year | -7.1% | +29.1% | -11.0% | +29.1% |
| alltime | all time | -7.1% | +5212.2% | -11.0% | +6004.1% |
Pfizer Retained earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $116.72B(-1.4%) | $116.72B(-3.6%) |
| Sep 2024 | - | $121.06B(+3.8%) |
| Jun 2024 | - | $116.60B(-3.9%) |
| Mar 2024 | - | $121.32B(+2.5%) |
| Dec 2023 | $118.35B(-5.8%) | $118.35B(-6.4%) |
| Sep 2023 | - | $126.41B(-1.9%) |
| Jun 2023 | - | $128.80B(-1.8%) |
| Mar 2023 | - | $131.10B(+4.3%) |
| Dec 2022 | $125.66B(+21.5%) | $125.66B(+2.2%) |
| Sep 2022 | - | $122.97B(+5.5%) |
| Jun 2022 | - | $116.61B(+4.9%) |
| Mar 2022 | - | $111.19B(+7.5%) |
| Dec 2021 | $103.39B(+14.4%) | $103.39B(+1.1%) |
| Sep 2021 | - | $102.25B(+6.1%) |
| Jun 2021 | - | $96.35B(+1.2%) |
| Mar 2021 | - | $95.16B(+5.3%) |
| Dec 2020 | $90.39B(-7.5%) | $90.39B(-9.9%) |
| Sep 2020 | - | $100.28B(+0.1%) |
| Jun 2020 | - | $100.20B(-0.8%) |
| Mar 2020 | - | $101.00B(+3.4%) |
| Dec 2019 | $97.67B(+9.1%) | $97.67B(-2.4%) |
| Sep 2019 | - | $100.11B(+6.0%) |
| Jun 2019 | - | $94.44B(+1.1%) |
| Mar 2019 | - | $93.39B(+4.3%) |
| Dec 2018 | $89.55B(+5.0%) | $89.55B(-2.7%) |
| Sep 2018 | - | $92.00B(+2.4%) |
| Jun 2018 | - | $89.86B(-0.1%) |
| Mar 2018 | - | $89.96B(+5.5%) |
| Dec 2017 | $85.29B(+18.8%) | $85.29B(+13.7%) |
| Sep 2017 | - | $75.04B(+1.3%) |
| Jun 2017 | - | $74.11B(-1.0%) |
| Mar 2017 | - | $74.85B(+4.3%) |
| Dec 2016 | $71.77B(-0.3%) | $71.77B(-1.5%) |
| Sep 2016 | - | $72.85B(-0.7%) |
| Jun 2016 | - | $73.35B(-2.2%) |
| Mar 2016 | - | $74.97B(+4.1%) |
| Dec 2015 | $71.99B(-0.3%) | $71.99B(-2.7%) |
| Sep 2015 | - | $74.02B(+0.5%) |
| Jun 2015 | - | $73.62B(-1.1%) |
| Mar 2015 | - | $74.47B(+3.2%) |
| Dec 2014 | $72.18B(+3.5%) | $72.18B(-2.8%) |
| Sep 2014 | - | $74.29B(+3.7%) |
| Jun 2014 | - | $71.63B(-0.6%) |
| Mar 2014 | - | $72.03B(+3.3%) |
| Dec 2013 | $69.73B(+28.6%) | $69.73B(-0.9%) |
| Sep 2013 | - | $70.38B(+4.1%) |
| Jun 2013 | - | $67.63B(+18.7%) |
| Mar 2013 | - | $56.97B(+5.0%) |
| Dec 2012 | $54.24B(+17.4%) | $54.24B(+5.8%) |
| Sep 2012 | - | $51.26B(+7.0%) |
| Jun 2012 | - | $47.90B(-0.5%) |
| Mar 2012 | - | $48.12B(+4.1%) |
| Dec 2011 | $46.21B(+8.2%) | $46.21B(-4.0%) |
| Sep 2011 | - | $48.12B(+8.6%) |
| Jun 2011 | - | $44.32B(-1.3%) |
| Mar 2011 | - | $44.93B(+5.2%) |
| Dec 2010 | $42.72B(+5.7%) | $42.72B(-0.4%) |
| Sep 2010 | - | $42.87B(+2.1%) |
| Jun 2010 | - | $42.01B(-1.0%) |
| Mar 2010 | - | $42.43B(+5.0%) |
| Dec 2009 | $40.43B(-17.7%) | $40.43B(-26.3%) |
| Sep 2009 | - | $54.84B(+5.5%) |
| Jun 2009 | - | $51.97B(+0.2%) |
| Mar 2009 | - | $51.86B(+5.5%) |
| Dec 2008 | $49.14B(-1.0%) | $49.14B(-7.6%) |
| Sep 2008 | - | $53.17B(+4.4%) |
| Jun 2008 | - | $50.91B(-2.9%) |
| Mar 2008 | - | $52.44B(+5.6%) |
| Dec 2007 | $49.66B(-0.0%) | $49.66B(-2.7%) |
| Sep 2007 | - | $51.06B(+1.5%) |
| Jun 2007 | - | $50.30B(-5.2%) |
| Mar 2007 | - | $53.06B(+6.8%) |
| Dec 2006 | $49.67B | $49.67B(+12.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2006 | - | $43.99B(+8.3%) |
| Jun 2006 | - | $40.63B(-2.6%) |
| Mar 2006 | - | $41.72B(+10.9%) |
| Dec 2005 | $37.61B(+6.0%) | $37.61B(-1.1%) |
| Sep 2005 | - | $38.03B(+4.4%) |
| Jun 2005 | - | $36.45B(+1.8%) |
| Mar 2005 | - | $35.78B(+0.8%) |
| Dec 2004 | $35.49B(+20.8%) | $35.49B(+0.4%) |
| Sep 2004 | - | $35.35B(+10.4%) |
| Jun 2004 | - | $32.00B(+0.9%) |
| Mar 2004 | - | $31.71B(+7.9%) |
| Dec 2003 | $29.38B(-2.8%) | $29.38B(-5.8%) |
| Sep 2003 | - | $31.19B(+7.8%) |
| Jun 2003 | - | $28.92B(-17.1%) |
| Mar 2003 | - | $34.91B(+15.4%) |
| Dec 2002 | $30.24B(+23.8%) | $30.24B(+3.9%) |
| Sep 2002 | - | $29.10B(+8.8%) |
| Jun 2002 | - | $26.74B(-0.2%) |
| Mar 2002 | - | $26.79B(+9.7%) |
| Dec 2001 | $24.43B(+24.6%) | $24.43B(+1.9%) |
| Sep 2001 | - | $23.97B(+9.4%) |
| Jun 2001 | - | $21.90B(+2.1%) |
| Mar 2001 | - | $21.44B(+9.4%) |
| Dec 2000 | $19.60B(+6.2%) | $19.60B(+0.8%) |
| Sep 2000 | - | $19.45B(+7.6%) |
| Jun 2000 | - | $18.09B(+24.1%) |
| Mar 2000 | - | $14.58B(-21.0%) |
| Dec 1999 | $18.46B(+61.4%) | $18.46B(+41.1%) |
| Sep 1999 | - | $13.09B(+5.8%) |
| Jun 1999 | - | $12.37B(+0.9%) |
| Mar 1999 | - | $12.25B(+7.1%) |
| Dec 1998 | $11.44B(+22.4%) | $11.44B(+910.1%) |
| Sep 1998 | - | $1.13B(-88.6%) |
| Jun 1998 | - | $9.93B(+1.3%) |
| Mar 1998 | - | $9.80B(+4.8%) |
| Dec 1997 | $9.35B(+16.6%) | $9.35B(-572.9%) |
| Sep 1997 | - | -$1.98B(-123.5%) |
| Jun 1997 | - | $8.41B(+0.2%) |
| Mar 1997 | - | $8.40B(+4.8%) |
| Dec 1996 | $8.02B(+16.9%) | $8.02B(+4.0%) |
| Sep 1996 | - | $7.71B(+7.1%) |
| Jun 1996 | - | $7.19B(+0.1%) |
| Mar 1996 | - | $7.18B(+4.7%) |
| Dec 1995 | $6.86B(+15.4%) | $6.86B(+3.7%) |
| Sep 1995 | - | $6.61B(+6.9%) |
| Jun 1995 | - | $6.19B(-0.2%) |
| Mar 1995 | - | $6.20B(+4.3%) |
| Dec 1994 | $5.94B(+13.4%) | $5.94B(+3.2%) |
| Sep 1994 | - | $5.76B(+6.2%) |
| Jun 1994 | - | $5.42B(-0.7%) |
| Mar 1994 | - | $5.46B(+4.2%) |
| Dec 1993 | $5.24B(+2.4%) | $5.24B(+3.0%) |
| Sep 1993 | - | $5.09B(-4.0%) |
| Jun 1993 | - | $5.30B(-0.3%) |
| Mar 1993 | - | $5.31B(+3.8%) |
| Dec 1992 | $5.12B(+6.8%) | $5.12B(-2.0%) |
| Sep 1992 | - | $5.23B(+6.0%) |
| Jun 1992 | - | $4.93B(-0.8%) |
| Mar 1992 | - | $4.97B(+3.6%) |
| Dec 1991 | $4.79B(+6.3%) | $4.79B(-2.2%) |
| Sep 1991 | - | $4.90B(+5.9%) |
| Jun 1991 | - | $4.63B(-0.9%) |
| Mar 1991 | - | $4.67B(+3.5%) |
| Dec 1990 | $4.51B(+9.9%) | $4.51B(+11.3%) |
| Sep 1990 | - | $4.05B(-3.8%) |
| Jun 1990 | - | $4.21B(-1.1%) |
| Mar 1990 | - | $4.26B(+3.7%) |
| Dec 1989 | $4.11B(+11.0%) | $4.11B(+11.0%) |
| Dec 1988 | $3.70B(+11.1%) | $3.70B(+11.1%) |
| Dec 1987 | $3.33B(+13.4%) | $3.33B(+13.4%) |
| Dec 1986 | $2.93B(+15.3%) | $2.93B(+15.3%) |
| Dec 1985 | $2.54B(+15.8%) | $2.54B(+15.8%) |
| Dec 1984 | $2.20B | $2.20B |
FAQ
- What is Pfizer annual retained earnings?
- What is the all time high annual retained earnings for Pfizer?
- What is Pfizer annual retained earnings year-on-year change?
- What is Pfizer quarterly retained earnings?
- What is the all time high quarterly retained earnings for Pfizer?
- What is Pfizer quarterly retained earnings year-on-year change?
What is Pfizer annual retained earnings?
The current annual retained earnings of PFE is $116.72B
What is the all time high annual retained earnings for Pfizer?
Pfizer all-time high annual retained earnings is $125.66B
What is Pfizer annual retained earnings year-on-year change?
Over the past year, PFE annual retained earnings has changed by -$1.63B (-1.38%)
What is Pfizer quarterly retained earnings?
The current quarterly retained earnings of PFE is $116.72B
What is the all time high quarterly retained earnings for Pfizer?
Pfizer all-time high quarterly retained earnings is $131.10B
What is Pfizer quarterly retained earnings year-on-year change?
Over the past year, PFE quarterly retained earnings has changed by $0.00 (0.00%)